Key Players in the Vietnam Carpal Tunnel Syndrome Market | Competitive Landscape 2026

Vietnam Carpal Tunnel Syndrome Market Overview

According to 6Wresearch, the Vietnam Carpal Tunnel Syndrome market is poised to expand, accelerated by an increased awareness and prevalence of repetitive strain injuries and peripheral nerve disorders. Carpal Tunnel Syndrome is a condition that affects hand function and nerve signalling, and is gaining recognition for its impact on quality of life.

The market is driven by the need to develop effective treatments, and also by an increasing momentum on neurological and musculoskeletal health. Moreover, organizations are investing in R&D to meet the demands of the people suffering from median nerve compression and chronic hand pain.

Competitive Landscape

The Vietnam Carpal Tunnel Syndrome Market is vastly competitive, with multinational pharmaceutical companies leveraging their strong R&D capabilities, to bring innovation in the treatment of nerve related disorders. The multinational pharmaceutical brands are now extending their footprint, through strategic partnerships and conducting clinical trials in the country.

Below is a list of leading players operating in the Vietnam Carpal Tunnel Syndrome Market:

1. Pfizer Inc.

Pfizer maintains a strong presence, focusing on pain management, and providing non-steroidal anti-inflammatory drugs, used in early-stage syndrome management.

2. Novartis International AG

Novartis contributes to the market through its expertise in neuroscience and pain relief, developing therapeutic solutions that address nerve inflammation.

3. GSK plc

GSK is a significant provider of analgesic and anti-inflammatory medications, offering brands that assist in managing the swelling and pain of symptoms.

4. Sanofi SA

Sanofi is a dominant force in general medicines, providing essential corticosteroid treatments and anti-inflammatory drugs.

5. Viatris Inc.

Viatris focuses on providing a broad portfolio of high-quality medicines, including established brands for neuropathic pain management.

6. Imexpharm Pharmaceutical Joint Stock Company

A leading local manufacturer with EU-GMP certified facilities, providing high-quality generic analgesics and vitamin B-complex supplements.

7. DHG Pharmaceutical Joint-Stock Company

DHG produces a wide range of supportive medications and topical pain-relief gels used in managing the discomfort and inflammatory symptoms.

8. Traphaco Joint Stock Company

Traphaco is highly regarded for its innovation in combining modern pharmaceutical standards with herbal-based supplements that aim to improve blood circulation.

9. Stellapharm J.V. Co., Ltd.

Specializes in high-tech generic medicines and maintains international quality standards to provide affordable, effective corticosteroid treatments.

10. Mekophar Chemical Pharmaceutical Joint Stock Company

A long-standing company specializing in both prescription and non-prescription essential drugs, ensuring the availability of neuropathic pain relievers and anti-inflammatory agents.